Interview with REBECCA project coordinator Prof. Dr Delopoulos & Amazona representative R. Middelveld
The interview with project coordinator Prof. Dr Delopoulos & Amazona representative R. Middelveld is finally out!
Dr Delopoulos, a professor of Electrical and Computer Engineering at the Aristotle University of Thessaloniki, and R. Middelveld, a breast cancer survivor and a member of a breast cancer society Amazona, discussed the novel characteristics of the REBECCA project.
New clinical research trend: Real-World Data collection
The interviewees showcased the new clinical research trend: Real-World Data collection from patients. The REBECCA project seeks to tap into the potential of Real-World Data with two goals in mind: to support clinical research and to improve existing clinical workflows in breast cancer treatment.
During the course of its run, partners will combine clinical data with data obtained from multiple wearables, online behaviour and registry data. This data will then be used to study the impact of primary and adjuvant cancer treatment on patients’ quality of life and assess the value of personalized patient monitoring to improve patient care.
Benefits for clinical research and patients
Prof. Dr Delopoulos highlighted the two ways in which REBECCA will benefit patients. First, by supporting clinical research with the use of Real-World Data, REBECCA can improve its accuracy and make it more productive. The output of this research aims to improve the quality of life for the entire patient population. Second, by using REBECCA as an intervention tool, patients can be better supported by their doctor. Real-World Data can offer more insights on a patient’s daily life, identify her problems and improve patient-doctor communication.
Are you curious about this project and would like to learn more? Watch the interview video!